SCHEMBL7933350

SCHEMBL7933350

CCc1cc(C)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 16/20 1.00
EDNRA P25101 16/20 1.00
NR1I2 O75469 1/20 0.80
KCNE1 P15382 1/20 0.80
KCNQ1 P51787 1/20 0.80
POLB P06746 1/20 0.80
KMT2A Q03164 1/20 0.62
IL36G Q9NZH8 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3023829 0.91 EDNRB (0.83) EDNRBEDNRANR1I2KCNE1KCNQ1
SCHEMBL3023827 0.91 EDNRB (0.83) EDNRBEDNRANR1I2KCNE1KCNQ1
Ambrisentan SCHEMBL138157 0.89 EDNRB (1.00) EDNRBEDNRANR1I2KCNE1KCNQ1
Ambrisentan SCHEMBL3679 0.89 EDNRB (1.00) EDNRBEDNRANR1I2KCNE1KCNQ1
Ambrisentan SCHEMBL20769813 0.89 EDNRB (1.00) EDNRBEDNRANR1I2KCNE1KCNQ1
Ambrisentan SCHEMBL3023434 0.89 EDNRB (1.00) EDNRBEDNRANR1I2KCNE1KCNQ1
SCHEMBL3030550 0.86 EDNRB (0.76) EDNRBEDNRANR1I2KCNE1KCNQ1
SCHEMBL3023738 0.86 EDNRB (0.76) EDNRBEDNRANR1I2KCNE1KCNQ1
SCHEMBL7934042 0.84 EDNRB (1.00) EDNRBEDNRANR1I2KCNE1KCNQ1
SCHEMBL3019879 0.83 EDNRB (0.82) EDNRBEDNRANR1I2KCNE1KCNQ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8404840-B2 Process for the preparation of endothelin receptor antagonists MSN LABORATORIES LIMITED (IL) 2013-03-26 US disclosed
WO-2010070658-A2 IMPROVED PROCESS FOR THE PREPARATION OF ENDOTHELIN RECEPTOR ANTAGONISTS MSN LABORATORIES LIMITED (IN) 2010-06-24 WO disclosed